We found 6 drugmaker programs for Immune Thrombocytopenia medicines and 5 charity funds (0 open at our last check). Tell us your insurance below and we'll show what to try first.
Help for Immune Thrombocytopenia depends mostly on how you're covered. Pick the one that sounds like you. We'll name the funds and programs that fit, and what won't work, so you don't waste a phone call.
Independent foundations pay copays, coinsurance and sometimes insurance premiums for people who already have coverage. Funds open and close as donations come in, so each one shows what the foundation said on the date we checked.
Covers: Medical and medication costs.
Covers: Insurance premiums and copays.
Covers: Copays, coinsurance, deductibles and other health-related expenses.
Covers: Copays, premiums or other treatment costs.
Covers: Out-of-pocket costs for approved medications. Up to $10,000 a year.
Copay cards lower what people with private insurance pay. Federal rules bar them for Medicare, Medicaid and TRICARE. Free medicine programs are for people without enough coverage and usually have income limits. We read each program on the drugmaker's own site.
Teva's Alvaiz Savings Program: patients with commercial prescription insurance that covers Alvaiz may pay as little as $0 out of pocket; maximum assistance per prescription and annual benefits apply. Not valid for uninsured or cash-paying patients or anyone enrolled in or eligible for Medicare, Medigap, Medicaid, VA, DoD, TRICARE or other government coverage. The current card expires December 31, 2026. Questions: 844-248-7949.
The Alvaiz site does not describe a free-drug program or a support hub; the savings program is managed by Mercalis for Teva.
Doptelet Copay Assistance Program: eligible patients with commercial insurance that covers Doptelet may pay as little as $0 per prescription, with an annual maximum of $15,000 per calendar year. Not available to patients enrolled in Medicare, Medicaid, Medigap, VA, DoD or TRICARE. Patients must be 1 year or older and live in the US or a US territory. Enrollment is valid through the calendar year.
Doptelet Connect enrolls patients in program offerings; call 1-833-368-2663, Monday to Friday, 8 AM to 7 PM ET.
Copay terms come from the program pop-up on doptelet.com. A free trial and an income-based patient assistance program are described on third-party listings but not on the official page we could read, so they are not listed here.
Amgen SupportPlus Co-Pay Program: patients with commercial or private insurance may pay as little as $0 out of pocket for each dose or cycle. It can be applied to deductible, co-insurance and co-payment, with no income eligibility requirement; eligibility criteria and program maximums apply.
Amgen SupportPlus offers financial support resources and patient support services, and for people without commercial or private insurance it can share information about independent nonprofit foundations. Call 866-264-2778, Monday to Friday, 9 AM to 8 PM ET.
Amgen reports that about 7 in 10 Nplate claims in 2023 to 2024 had $0 out-of-pocket cost, commercial and Medicare combined (IQVIA claims data). Full co-pay terms are at AmgenSupportPlus.com/copay.
Universal Co-pay Program: eligible patients with private insurance may pay $0 per month; Novartis pays up to $15,000 per calendar year.
Novartis Patient Support can answer questions about paying for PROMACTA; call 1-800-282-7630.
Co-pay program not valid with Medicare, Medicaid or other government coverage; enroll at Copay.NovartisOncology.com or 1-877-577-7756. PROMACTA is not on the Novartis Patient Assistance Foundation's current medication list, and no free-drug program is described on the PROMACTA site.
Tavalisse Copay Assistance Program: eligible patients with commercial insurance pay as little as $0 per prescription dispense. Sign up at tavalissecopay.com. Must be a US or US territory resident; restrictions apply.
Rigel OneCare's patient support team checks insurance coverage, determines eligibility for copay and financial assistance programs and helps with enrollment. Call 1-833-744-3562 or 650-449-8646, Monday to Friday, 8 AM to 8 PM ET.
Tavalisse.com mentions financial assistance beyond the copay program without describing it; third-party listings describe a free drug supply and an income-based program, which are not listed here until confirmed on Rigel's own pages. The FDA approved an AB-rated generic from Annora Pharma on June 17, 2026; launch unconfirmed.
Wayrilz Copay Assistance Program: eligible patients may pay as little as $0 in copay per fill. Not valid for patients using Medicare (including Part D), Medicaid, Medigap, VA, DoD, TRICARE or state pharmaceutical assistance programs to pay for Wayrilz. Enroll with the healthcare provider's enrollment form, online at SanofiHemAssist.com, or through a HemAssist Case Manager.
Free Trial Program: the first month's supply of Wayrilz with an enrollment form and valid prescription. Valid only for a patient's first prescription, once per lifetime, and not valid in Vermont. The page does not limit it by insurance type; free product may not be billed to any insurer.
HemAssist Patient Assistance Program: may help eligible Wayrilz patients who are uninsured, underinsured or have a temporary loss of insurance coverage. Income limits are not published on the page.
A Case Manager verifies insurance coverage and identifies financial help, and a Clinical Educator provides education about Wayrilz and ITP. Call Monday to Friday, 8 AM to 7 PM ET.
HemAssist covers all of Sanofi's rare blood disorder medicines. The Wayrilz page lists 1-833-723-5463 throughout, with one line showing 1-833-723-4563, which appears to be a typo; wayrilz.com also lists 1-833-723-5463.
Most of these programs start with one call, and having these ready makes it shorter. Tick them off as you go. Nothing here is saved or sent anywhere.
Call the drugmaker's support line first. Its case managers check your benefits and often fill out forms with your doctor. If a charity fund is closed, sign up on the foundation's page to hear when it reopens. Most programs need renewing every year, and many copay cards reset in January.
Yes. Trial Friend lists 6 drugmaker programs for Immune Thrombocytopenia medicines and 5 charity funds, 0 of them open at our last check. We checked every one at the source on or before October 19, 2026. Which ones fit depends on your insurance. Copay cards are for people with private insurance, charity funds usually need some insurance, and free medicine programs are for people without enough coverage.
No. Federal rules bar drugmaker copay cards for drugs paid by Medicare, Medicaid or TRICARE. For Immune Thrombocytopenia, 0 charity funds on this page accept Medicare, and 0 drugmaker free medicine programs name Medicare patients among those who may qualify. In 2026, Medicare Part D also caps yearly out-of-pocket costs for covered drugs at $2,100.
None of the 5 funds listed for Immune Thrombocytopenia was open to new applicants at our last check. Funds reopen when new donations arrive, and each foundation lets you sign up to hear when one opens.
Of the drugmaker programs for Immune Thrombocytopenia medicines, 1 offers free medicine to people without insurance who qualify, usually with income limits. Most charity funds pay copays and premiums, so they need some insurance. The drugmaker's support line can also check whether you qualify for coverage you don't have yet.
How we check: drugmaker programs come only from each drugmaker's own pages. Fund status is copied from each foundation's list (NORD RareCare, The Assistance Fund, HealthWell Foundation, TotalAssist) on the date shown. Programs change, so confirm with the program before you rely on it. Trial Friend shares information, not financial, legal or medical advice, and each program decides who qualifies. See something wrong? Email jason@trialfriend.com.
